Drug Profile
Research programme: mitochondrial biogenesis inducers - Mitohealth
Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Mitohealth
- Class
- Mechanism of Action Mitochondrial protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Metabolic-disorders in USA
- 14 Aug 2016 Early research in Metabolic disorders in USA (unspecified route)